• Exchange: NASDAQ GS
  • Sector: Health Care
  • Industry: Biotech & Pharma
  • Sub-Industry: Specialty Pharma

SHPG:US

244.3500 USD 0.5100 0.21%

As of 20:10:00 ET on 08/29/2014.

Snapshot for Shire PLC (SHPG)

Open: 244.3200 Day's Range: 243.1800 - 245.2100 Volume: 717,154
Previous Close: 244.8600 52wk Range: 109.9600 - 258.5500 1-Yr Rtn: +122.54%

Stock Chart for SHPG

No chart data available.
  • SHPG:US 244.3500
  • 1D
  • 1M
  • 1Y
244.8600
Interactive SHPG Chart

Previous Close

No chart data available.
Interactive Chart
  • 1D
  • 1W
  • 1M
  • YTD
  • 1Y
  • 3Y
  • 5Y
Close:
Open:
High:
Low:
Volume:
Recently Viewed Symbols
Save as Watchlist
Saving as watchlist...

Key Statistics for SHPG

Current P/E Ratio (ttm) -
Estimated P/E(12/2014) 25.0102
Relative P/E vs. SPX -
Earnings Per Share (USD) (ttm) -
Est. EPS (USD) (12/2014) 9.7700
Est. PEG Ratio 2.0158
Market Cap (M USD) 48,019.87
Shares Outstanding (M) 196.52
30 Day Average Volume 1,564,271
Price/Book (mrq) -
Price/Sale (ttm) -
Dividend Indicated Gross Yield 0.09%
Cash Dividend (USD) 0.1149
Dividend Ex-Date 09/03/2014
5 Year Dividend Growth 15.00%
Next Earnings Announcement 10/24/2014
mrq = Most Recent Quarter; ttm = Trailing Twelve Months

Income Statement for SHPG

  • Revenue
  • Net Income (M/USD)
  • Profit Margin (%)

Company Profile & Key Executives for SHPG

Shire PLC markets, licenses and develops prescription medicines. The Group focuses its operations on attention deficit and hyperactivity disorders, human genetic therapies, gastrointestinal, and renal diseases.

Flemming OrnskovChief Executive OfficerJames BowlingInterim CFO/Senior VP/Controller
Tatjana MaySecretary/General CounselJeff PoultonHead:Investor Relations
More Company Profile & Key Executives for SHPG

Quotes delayed, except where indicated otherwise. All prices in local currency. Time is ET.

Sponsored Link
Advertisement
Advertisement
Sponsored Links
Advertisements
sec ||= nil